Market Cap (In USD)
1.99 Million
Revenue (In USD)
-
Net Income (In USD)
-
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-5-0.0115
- PE
- -
- EPS
- -
- Beta Value
- 11.554
- ISIN
- CA46501D1087
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ajay Singh Kaila
- Employee Count
- -
- Website
- https://www.isracann.com
- Ipo Date
- 2017-12-15
- Details
- Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
More Stocks
-
1407
-
SCM
-
SLTTFSlate Office REIT
SLTTF
-
OVOBELEOvobel Foods Limited
OVOBELE
-
9974Belc CO., LTD.
9974
-
ACLXArcellx, Inc.
ACLX
-
603788
-
9386